pI: 9.7978 |
Length (AA): 174 |
MW (Da): 19579 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
53 | 106 | 3mcb (A) | 79 | 132 | 24.00 | 0.00000014 | 0.21 | 0.508345 | 0.58 |
72 | 114 | 3bvp (A) | 70 | 112 | 37.00 | 0.99 | 0.15 | 0.641326 | -0.2 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127333)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G17880 | basic transcription factor 3 |
Arabidopsis thaliana | AT1G73230 | nascent polypeptide-associated complex subunit beta |
Babesia bovis | BBOV_III010510 | NAC domain containing protein |
Brugia malayi | Bm1_43925 | beta-NAC-like protein |
Candida albicans | CaO19.8746 | similar to S. cerevisiae GAL4 enhancer protein EGD1 (YPL037C) subunit alpha of the nascent polypeptide-associated chaperone comp |
Candida albicans | CaO19.1154 | similar to S. cerevisiae GAL4 enhancer protein EGD1 (YPL037C) subunit alpha of the nascent polypeptide-associated chaperone comp |
Caenorhabditis elegans | CELE_C56C10.8 | Protein ICD-1 |
Cryptosporidium hominis | Chro.60282 | NAC domain protein |
Cryptosporidium parvum | cgd6_2430 | BTF domain, basal transcription factor |
Dictyostelium discoideum | DDB_G0281795 | nascent polypeptide-associated complex NAC domain-containing protein |
Drosophila melanogaster | Dmel_CG3644 | bicaudal |
Echinococcus granulosus | EgrG_000176200 | transcription factor btf3 |
Entamoeba histolytica | EHI_198870 | transcription factor BTF3, putative |
Entamoeba histolytica | EHI_048560 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000176200 | transcription factor btf3 |
Homo sapiens | ENSG00000134717 | basic transcription factor 3-like 4 |
Homo sapiens | ENSG00000145741 | basic transcription factor 3 |
Leishmania braziliensis | LbrM.35.4010 | basic transcription factor 3a, putative |
Leishmania donovani | LdBPK_363960.1 | transcription factor btf3, putative |
Leishmania infantum | LinJ.36.3960 | basic transcription factor 3a, putative |
Leishmania major | LmjF.36.3770 | basic transcription factor 3a, putative |
Leishmania mexicana | LmxM.36.3770 | basic transcription factor 3a, putative |
Loa Loa (eye worm) | LOAG_03020 | ICD-1 protein |
Mus musculus | 100048185 | predicted gene, 29692 |
Mus musculus | ENSMUSG00000028568 | basic transcription factor 3-like 4 |
Mus musculus | 101055993 | predicted gene 29138 |
Mus musculus | ENSMUSG00000021660 | basic transcription factor 3 |
Neospora caninum | NCLIV_029860 | hypothetical protein |
Oryza sativa | 4331347 | Os03g0109600 |
Oryza sativa | 4348929 | Os10g0483000 |
Oryza sativa | 4334799 | Os03g0851000 |
Plasmodium berghei | PBANKA_1018500 | transcription factor 3b, putative |
Plasmodium falciparum | PF3D7_1426100 | basic transcription factor 3b, putative |
Plasmodium knowlesi | PKNH_1332600 | basic transcription factor 3b, putative |
Plasmodium vivax | PVX_085220 | basic transcription factor 3b, putative |
Plasmodium yoelii | PY05141 | basic transcription factor 3, putative |
Saccharomyces cerevisiae | YPL037C | Egd1p |
Schistosoma japonicum | Sjp_0102880 | ko:K01527 nascent polypeptide-associated complex subunit beta, putative |
Schistosoma mansoni | Smp_002180.2 | transcription factor btf3 |
Schmidtea mediterranea | mk4.000346.03 | Transcription factor BTF3 homolog |
Schmidtea mediterranea | mk4.000504.07 | Transcription factor BTF3 homolog |
Trypanosoma brucei gambiense | Tbg972.11.10890 | nascent polypeptide associated complex alpha subunit, putative |
Trypanosoma brucei | Tb927.11.9700 | transcription factor BTF3, putative |
Trypanosoma cruzi | TcCLB.504017.10 | transcription factor btf3, putative |
Trypanosoma cruzi | TcCLB.511231.80 | transcription factor btf3, putative |
Toxoplasma gondii | TGME49_257090 | NAC domain-containing protein |
Theileria parva | TP02_0090 | transcription factor BTF3, putative |
Trichomonas vaginalis | TVAG_072140 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_265540 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_435990 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.1465 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1465 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1465 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.1465 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C56C10.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C56C10.8 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C56C10.8 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_1018500 | Plasmodium berghei | Essential | plasmo |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Streptococcus pyogenes | Streptokinase | Compounds | References |
Streptococcus pyogenes serotype M1 | Streptokinase A | Compounds | References |